Streptococcus
pyogenes (group A beta streptococci)
Organism
Habitat
- Asymptomatic colonization of the
upper respiratory tract in humans.
Source
- Pharyngitis is pread person to
person primarily by respiratory droplets; skin infections are spread by direct
contact with an infected person or through fomites (def).
Epidemiology
Clinical Disease
- The most common infection is pharyngitis
(streptococcal sore throat) with the organism usually being limited to
the mucous membranes and lymphatic tissue of the upper respiratory tract.
From the pharynx, however,
the streptococci sometimes spread to other areas of the respiratory
tract resulting in laryngitis (def),
bronchitis (def),
pneumonia, and otitis media (def).
- Occasionally, it may enter the
lymphatic vessels or the blood and disseminate to other areas of the
body, causing septicemia (def),
osteomyelitis (def),
endocarditis(def),
septic arthritis (def),
and meningitis (def).
- If it enters injured skin, it
may cause pyogenic (def)
cutaneous infections such as impetigo , erysipelas (def),
orcellulitis (def).
- Group A beta streptococcus infections
can result in two autoimmune diseases (def),
rheumatic fever and acute glomerulonephritis, where antibodies made against
streptococcal antigens cross react with joint membranes and heart valve tissue
in the case of rheumatic fever, or glomerular cells and basement membranes
of the kidneys in the case of acute glomerulonephritis.
- Certain
strains of S. pyogenes cause invasive group A beta streptococcal
infections. Each year in the U.S. there are between 750 and 1500 cases of
necrotizing fasciitis
where a streptococcal-coded protease called Exotoxin B destroys the muscle
(myositis) or the muscle covering (necrotizing fasciitis). There are another
750 - 1500 cases of toxic shock-like syndrome (def)
due to group A beta streptococci producing Streptococcal pyrogenic exotoxin
(Spe).
From Streptococcus
Group A Infections, by Sat Sharma, MD, FRCPC, FACP, FCCP, DABSM, Program
Director, Associate Professor, Department of Internal Medicine, Divisions of
Pulmonary and Critical Care Medicine, University of Manitoba; Site Coordinator
of Respiratory Medicine, St Boniface General Hospital; and Godfrey
Harding, MD, FRCPC, Program Director of Medical Microbiology, Professor, Department
of Medicine, Section of Infectious Diseases and Microbiology, St Boniface Hospital,
University of Manitoba, Canada.